In accordance we show that Ex4 blocks the nicotine-induced expression of locomotor sensitization in mice, indicating that GLP-1 analogues deserve to be evaluated as a potential novel treatment target for smoking cessation and other nicotine addictions. This evidence concerns the gene GCG and nicotine dependence.